Iqvia Holdings IQV
NYSE IQV
$269.47 +0.65 (+0.24%)
As of: Sep 17, 2026 · 3:59 PM EDT

Iqvia Holdings (IQV) Total Debt Growth (5y) (2017 - 2026)

Analysis

Iqvia Holdings (IQV) Total Debt Growth (5y) (2017 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Iqvia Holdings 44.72 Bn 42.64 Bn 1.44 Bn
2 Medpace Holdings 17.37 Bn 16.87 Bn 201.64 Mn
3 Icon 13.65 Bn 12.72 Bn 479.29 Mn
4 Charles River Laboratories International 13.13 Bn 12.94 Bn 452.07 Mn
5 Fortrea Holdings 1.89 Bn 1.72 Bn 139.20 Mn
6 Evotec SE 574.75 Mn 148.87 Mn -
7 Ginkgo Bioworks Holdings 439.63 Mn 355.09 Mn 18.44 Mn
8 Champions Oncology 69.43 Mn 65.03 Mn 7.70 Mn
9 MindWalk Holdings 51.76 Mn 46.29 Mn 1.61 Mn
10 VivoSim Labs 1.37 Mn 1.37 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 5.42%
Mar 31, 2026 5.29%
Dec 31, 2025 4.64%
Sep 30, 2025 3.92%
Jun 30, 2025 5.05%
Mar 31, 2025 3.56%
Dec 31, 2024 3.73%
Sep 30, 2024 3.20%
Jun 30, 2024 3.07%
Mar 31, 2024 3.70%
Dec 31, 2023 4.43%
Sep 30, 2023 5.12%
Jun 30, 2023 5.13%
Mar 31, 2023 4.75%
Dec 31, 2022 4.51%
Sep 30, 2022 4.91%
Jun 30, 2022 7.36%
Mar 31, 2022 8.65%
Dec 31, 2021 10.99%
Sep 30, 2021 37.96%